Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05314088 · ClinicalTrials.gov registry record · NA

Testing the Efficacy and Mechanisms of an Adapted Resilience Building Intervention in People Aging With HIV

A NA study of HIV-1-infection and Stress, Psychological, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
106
Enrollment target
1
Study location

NCT05314088 is a NA study of HIV-1-infection and Stress, Psychological that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 106 participants, below the 350-participant average among 71 other HIV-1-infection trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05314088, a NA study of HIV-1-infection and Stress, Psychological, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
106 participants
Enrollment target
1
Study location

Study Summary

This study will examine the mechanisms and efficacy of a resilience building intervention in older people living with HIV.

Interventions

  • BEHAVIORAL RISE+
  • BEHAVIORAL Stress Reduction Control

Study Locations (1)

Alabama

  • Holley Mears Building - Birmingham

Trial Details

FieldValue
Enrollment Target 106 participants
Start Date 2023-02-03
Est. Completion 2025-05-31
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT05314088

The ClinicalTrials.gov registry entry for NCT05314088 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 350-participant average among 71 other HIV-1-infection trials with a reported enrollment target (70% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with HIV-1-infection appearing as the primary indexed condition, and to 2 interventions - of which RISE+ is the first listed.

NCT05314088 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT05314088 about?

NCT05314088 is a clinical study titled "Testing the Efficacy and Mechanisms of an Adapted Resilience Building Intervention in People Aging With HIV". This study will examine the mechanisms and efficacy of a resilience building intervention in older people living with HIV.

What is the current status of trial NCT05314088?

This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2023-02-03. Estimated completion is 2025-05-31.

What conditions does trial NCT05314088 study?

This clinical trial studies the following conditions: HIV-1-infection, Stress, Psychological, Resilience.

What interventions are being tested in trial NCT05314088?

The interventions under investigation include: RISE+ (BEHAVIORAL), Stress Reduction Control (BEHAVIORAL).

Who is sponsoring clinical trial NCT05314088?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05314088 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV-1-infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.